Leinco Technologies is a leader in the development and manufacturing of recombinant antibodies for early discovery research and diagnostics. We offer an extensive line of recombinant biosimilar antibodies at the In vivo functional purity levels you have come to know and trust from Leinco Technologies. Recombinant biosimilar antibodies are designated for research use only and may not be used for therapeutics. Leinco’s biosimilars are made available to researchers to avoid purchasing therapeutic antibodies at pharmaceutical prices for important groundbreaking experiments. Learn more about Leinco’s industry leading purity specifications, current product offerings and custom services.

Format
Reactivity Species
Host Species
Category
Reported Applications
10 per page
Sort by

Toggle Details

Showing 1 – 10 of 118 results Showing all 118 results Showing the single result No results found
Name
Fc Effector Activity
Applications ?
Prod No.
Clone
Pkg. Size / Quantity
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
Active
CyTOF®
,
ELISA
,
FC
,
IHC
LT1500
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
Active
FC
,
IHC
LT1503
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
Active
ELISA
,
FC
LT1501
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
Active
FC
,
IHC
LT1511
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
Active
ELISA
,
FC
LT1502
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
Active
FC
,
IHC
LT1504
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
Muted
CyTOF®
,
ELISA
,
FC
,
IHC
LT1505
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
Muted
ELISA
,
FC
LT1506
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ErbB-2, NEU, NGL, HER2, TKR1, CD340, MLN 19, HER-2/neu
Reactivity:
Human
Immunogen:
Human epidermoid carcinoma cells (A431) over-expressing EGFR.
Muted
ELISA
,
FC
LT1507
4D5-8
Max:
Min: 1
Step: 1
Alt Names:
ITGAL; integrin alpha L; LFA-1; LFA1A
Reactivity:
Human
Immunogen:
Human CD11a
Active
B
,
CyTOF®
,
ELISA
,
FA
,
FC
,
IHC
LT800
hu1124
Max:
Min: 1
Step: 1
1 2 12